Elotrace
Recall
|
Medicines
|
24/05/2017
The marketing authorization holder has informed its supplied customers in a letter dated May 23, 2017, that increased black visible particles have been detected in a batch of "Elotrace - Infusion Additive".Based on these observations, the affected batch 16LC6994 is being recalled.
| Name of the medicinal product | Elotrace - Infusionszusatz |
|---|---|
| Marketing authorisation number(s) | 1-21430 |
| Marketing authorisation holder | Fresenius Kabi Austria GmbH |
| Batch number(s) | 16LC6994 |
| Classification of the recall | 2 |
| BASG reference number | INS-640.001-2 119 |
Further inquiry note
Page last modified:
12/07/2022